Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Eli Lilly and Company | LLY | $1,270.75 | $1.13T | 42.7 | 0.54% |
| Johnson & Johnson | JNJ | $257.78 | $621.22B | 39.1 | 2.07% |
| AbbVie Inc. | ABBV | $284.80 | $503.27B | 80.5 | 2.39% |
| UnitedHealth Group Incorporated | UNH | $417.00 | $374.30B | 26.8 | 2.21% |
| Merck & Co., Inc. | MRK | $149.88 | $369.78B | 119.0 | 2.29% |
| Novartis AG | NVS | $153.93 | $292.58B | 23.3 | 3.09% |
| AstraZeneca PLC | AZN | $168.45 | $261.82B | 25.2 | 1.95% |
| Thermo Fisher Scientific Inc. | TMO | $694.02 | $256.61B | 37.4 | 0.27% |
| Amgen Inc. | AMGN | $438.34 | $236.98B | 27.2 | 2.30% |
| Gilead Sciences, Inc. | GILD | $153.57 | $190.42B | 2.10% | |
| Abbott Laboratories | ABT | $100.51 | $173.92B | 32.4 | 2.46% |
| Novo Nordisk A/S | NVO | $39.06 | $172.38B | 9.6 | 4.57% |
| Pfizer Inc. | PFE | $29.85 | $170.14B | 39.3 | 5.71% |
| Danaher Corporation | DHR | $233.86 | $164.40B | 41.7 | 0.71% |
| Intuitive Surgical, Inc. | ISRG | $428.12 | $151.25B | 51.8 | — |
| Vertex Pharmaceuticals Incorporated | VRTX | $524.52 | $132.95B | 30.4 | — |
| Bristol-Myers Squibb Company | BMY | $61.12 | $124.85B | 13.5 | 4.09% |
| CVS Health Corporation | CVS | $93.45 | $119.52B | 24.6 | 2.81% |
| Medtronic plc. | MDT | $93.03 | $119.00B | 22.9 | 3.04% |
| McKesson Corporation | MCK | $1,015.50 | $118.40B | 27.2 | 0.37% |
| Stryker Corporation | SYK | $297.60 | $114.15B | 30.8 | 1.16% |
| GSK plc | GSK | $50.02 | $100.22B | 15.8 | 3.59% |
| HCA Healthcare, Inc. | HCA | $459.40 | $99.46B | 15.4 | 0.67% |
| Sanofi | SNY | $40.97 | $98.17B | 21.6 | 5.84% |
| Moderna, Inc. | MRNA | $245.81 | $98.14B | — | |
| Elevance Health, Inc. | ELV | $434.13 | $94.15B | 19.2 | 1.56% |
| Regeneron Pharmaceuticals, Inc. | REGN | $805.67 | $82.95B | 19.9 | 0.47% |
| The Cigna Group | CI | $304.37 | $79.88B | 12.5 | 2.06% |
| Cencora, Inc. | COR | $340.43 | $64.96B | 25.3 | 0.70% |
| Boston Scientific Corporation | BSX | $44.51 | $64.33B | 18.0 | — |
| Takeda Pharmaceutical Company Limited | TAK | $19.93 | $63.67B | 3.07% | |
| Natera, Inc. | NTRA | $413.38 | $59.59B | — | |
| Cardinal Health, Inc. | CAH | $257.46 | $58.83B | 35.1 | 0.81% |
| argenx SE | ARGX | $890.05 | $55.97B | 33.9 | — |
| Becton, Dickinson and Company | BDX | $194.34 | $52.79B | 45.1 | 2.20% |
| Veeva Systems Inc. | VEEV | $320.55 | $51.90B | 52.6 | — |
| Humana Inc. | HUM | $425.42 | $51.08B | 40.2 | 0.83% |
| Edwards Lifesciences Corporation | EW | $88.40 | $50.95B | 52.6 | — |
| Agilent Technologies, Inc. | A | $177.75 | $50.12B | 35.1 | 0.59% |
| Medline Inc. | MDLN | $35.31 | $47.51B | 88.3 | — |
| Teva Pharmaceutical Industries Limited | TEVA | $40.62 | $47.37B | 67.7 | — |
| IQVIA Holdings Inc. | IQV | $276.63 | $45.53B | 34.4 | — |
| Waters Corporation | WAT | $457.47 | $44.92B | 115.8 | — |
| Haleon plc | HLN | $10.02 | $44.06B | 20.5 | 1.95% |
| BeOne Medicines AG | ONC | $386.46 | $43.97B | 69.1 | — |
| IDEXX Laboratories, Inc. | IDXX | $553.48 | $43.60B | 38.9 | — |
| Illumina, Inc. | ILMN | $282.86 | $42.71B | 52.8 | — |
| Revolution Medicines, Inc. | RVMD | $194.28 | $41.64B | — | |
| Royalty Pharma plc | RPRX | $62.15 | $35.91B | 33.1 | 1.51% |
| ResMed Inc. | RMD | $246.20 | $34.63B | 23.6 | 1.08% |
Eli Lilly and Company
Healthcare / Drug Manufacturers - General
- Market Cap
- $1.13T
- P/E
- 42.7
- Dividend Yield
- 0.54%
Johnson & Johnson
Healthcare / Drug Manufacturers - General
- Market Cap
- $621.22B
- P/E
- 39.1
- Dividend Yield
- 2.07%
AbbVie Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $503.27B
- P/E
- 80.5
- Dividend Yield
- 2.39%
UnitedHealth Group Incorporated
Healthcare / Healthcare Plans
- Market Cap
- $374.30B
- P/E
- 26.8
- Dividend Yield
- 2.21%
Merck & Co., Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $369.78B
- P/E
- 119.0
- Dividend Yield
- 2.29%
Novartis AG
Healthcare / Drug Manufacturers - General
- Market Cap
- $292.58B
- P/E
- 23.3
- Dividend Yield
- 3.09%
AstraZeneca PLC
Healthcare / Drug Manufacturers - General
- Market Cap
- $261.82B
- P/E
- 25.2
- Dividend Yield
- 1.95%
Thermo Fisher Scientific Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $256.61B
- P/E
- 37.4
- Dividend Yield
- 0.27%
Amgen Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $236.98B
- P/E
- 27.2
- Dividend Yield
- 2.30%
Gilead Sciences, Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $190.42B
- P/E
- unprofitable
- Dividend Yield
- 2.10%
Abbott Laboratories
Healthcare / Medical Devices
- Market Cap
- $173.92B
- P/E
- 32.4
- Dividend Yield
- 2.46%
Novo Nordisk A/S
Healthcare / Drug Manufacturers - General
- Market Cap
- $172.38B
- P/E
- 9.6
- Dividend Yield
- 4.57%
Pfizer Inc.
Healthcare / Drug Manufacturers - General
- Market Cap
- $170.14B
- P/E
- 39.3
- Dividend Yield
- 5.71%
Danaher Corporation
Healthcare / Diagnostics & Research
- Market Cap
- $164.40B
- P/E
- 41.7
- Dividend Yield
- 0.71%
Intuitive Surgical, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $151.25B
- P/E
- 51.8
Vertex Pharmaceuticals Incorporated
Healthcare / Biotechnology
- Market Cap
- $132.95B
- P/E
- 30.4
Bristol-Myers Squibb Company
Healthcare / Drug Manufacturers - General
- Market Cap
- $124.85B
- P/E
- 13.5
- Dividend Yield
- 4.09%
CVS Health Corporation
Healthcare / Healthcare Plans
- Market Cap
- $119.52B
- P/E
- 24.6
- Dividend Yield
- 2.81%
Medtronic plc.
Healthcare / Medical Devices
- Market Cap
- $119.00B
- P/E
- 22.9
- Dividend Yield
- 3.04%
McKesson Corporation
Healthcare / Medical Distribution
- Market Cap
- $118.40B
- P/E
- 27.2
- Dividend Yield
- 0.37%
Stryker Corporation
Healthcare / Medical Devices
- Market Cap
- $114.15B
- P/E
- 30.8
- Dividend Yield
- 1.16%
GSK plc
Healthcare / Drug Manufacturers - General
- Market Cap
- $100.22B
- P/E
- 15.8
- Dividend Yield
- 3.59%
HCA Healthcare, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $99.46B
- P/E
- 15.4
- Dividend Yield
- 0.67%
Sanofi
Healthcare / Drug Manufacturers - General
- Market Cap
- $98.17B
- P/E
- 21.6
- Dividend Yield
- 5.84%
Moderna, Inc.
Healthcare / Biotechnology
- Market Cap
- $98.14B
- P/E
- unprofitable
Elevance Health, Inc.
Healthcare / Healthcare Plans
- Market Cap
- $94.15B
- P/E
- 19.2
- Dividend Yield
- 1.56%
Regeneron Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $82.95B
- P/E
- 19.9
- Dividend Yield
- 0.47%
The Cigna Group
Healthcare / Healthcare Plans
- Market Cap
- $79.88B
- P/E
- 12.5
- Dividend Yield
- 2.06%
Cencora, Inc.
Healthcare / Medical Distribution
- Market Cap
- $64.96B
- P/E
- 25.3
- Dividend Yield
- 0.70%
Boston Scientific Corporation
Healthcare / Medical Devices
- Market Cap
- $64.33B
- P/E
- 18.0
Takeda Pharmaceutical Company Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $63.67B
- P/E
- unprofitable
- Dividend Yield
- 3.07%
Natera, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $59.59B
- P/E
- unprofitable
Cardinal Health, Inc.
Healthcare / Medical Distribution
- Market Cap
- $58.83B
- P/E
- 35.1
- Dividend Yield
- 0.81%
argenx SE
Healthcare / Biotechnology
- Market Cap
- $55.97B
- P/E
- 33.9
Becton, Dickinson and Company
Healthcare / Medical Instruments & Supplies
- Market Cap
- $52.79B
- P/E
- 45.1
- Dividend Yield
- 2.20%
Veeva Systems Inc.
Healthcare / Health Information Services
- Market Cap
- $51.90B
- P/E
- 52.6
Humana Inc.
Healthcare / Healthcare Plans
- Market Cap
- $51.08B
- P/E
- 40.2
- Dividend Yield
- 0.83%
Edwards Lifesciences Corporation
Healthcare / Medical Devices
- Market Cap
- $50.95B
- P/E
- 52.6
Agilent Technologies, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $50.12B
- P/E
- 35.1
- Dividend Yield
- 0.59%
Medline Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $47.51B
- P/E
- 88.3
Teva Pharmaceutical Industries Limited
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $47.37B
- P/E
- 67.7
IQVIA Holdings Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $45.53B
- P/E
- 34.4
Waters Corporation
Healthcare / Diagnostics & Research
- Market Cap
- $44.92B
- P/E
- 115.8
Haleon plc
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $44.06B
- P/E
- 20.5
- Dividend Yield
- 1.95%
BeOne Medicines AG
Healthcare / Biotechnology
- Market Cap
- $43.97B
- P/E
- 69.1
IDEXX Laboratories, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $43.60B
- P/E
- 38.9
Illumina, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $42.71B
- P/E
- 52.8
Revolution Medicines, Inc.
Healthcare / Biotechnology
- Market Cap
- $41.64B
- P/E
- unprofitable
Royalty Pharma plc
Healthcare / Biotechnology
- Market Cap
- $35.91B
- P/E
- 33.1
- Dividend Yield
- 1.51%
ResMed Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $34.63B
- P/E
- 23.6
- Dividend Yield
- 1.08%
Showing 1–50 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.
Key facts
As of October 21, 2026, 1,092 Healthcare stocks are listed: 1,045 on NYSE & NASDAQ, 36 on TSX (Toronto Stock Exchange), and 11 on other venues. A company listed on more than one exchange is counted once.
The largest by market capitalization is Eli Lilly and Company (LLY) at $1.13T.
Healthcare Sector Overview
From the data · Oct 21, 2026The Healthcare sector includes 1,092 publicly traded companies with a combined market capitalization of $9.59T in US dollars. A further CA$22.73B is quoted in CAD, across 36 listed companies. The sector is led by Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), which together represent a significant share of total sector value. These companies span a diverse range of business models and sub-industries, making the Healthcare sector one of the most closely followed segments of the equity market.
Healthcare Sector Valuation
The Healthcare sector currently trades at an average P/E ratio of 50.0x — a growth premium, indicating that investors expect above-average earnings expansion from sector companies. Comparing this figure against broader market averages and historical norms can help investors assess whether the sector is trading at a discount or premium. The average dividend yield among payers stands at 1.91%, contributing an income component to total returns for sector investors.
Largest Healthcare Companies
| Company | Ticker | Market Cap | P/E Ratio |
|---|---|---|---|
| Eli Lilly and Company | LLY | $1.13T | 42.7 |
| Johnson & Johnson | JNJ | $621.22B | 39.1 |
| AbbVie Inc. | ABBV | $503.27B | 80.5 |
| UnitedHealth Group Incorporated | UNH | $374.30B | 26.8 |
| Merck & Co., Inc. | MRK | $369.78B | 119.0 |
Healthcare Dividend Profile
81 out of 1,092 Healthcare companies (7%) currently pay a dividend, with dividend payers representing a smaller, income-oriented subset of the sector. The average dividend yield among paying companies is 1.91%, providing a meaningful income stream for long-term holders. Dividend sustainability and payout ratios are key metrics to evaluate when building an income-focused portfolio within this sector.
Healthcare Sub-Industries
The Healthcare sector is divided into 11 sub-industries, each with its own growth dynamics, risk profile, and competitive landscape.
- Biotechnology — 608 companies, led by Vertex Pharmaceuticals Incorporated
- Medical Devices — 145 companies, led by Abbott Laboratories
- Drug Manufacturers - Specialty & Generic — 97 companies, led by Takeda Pharmaceutical Company Limited
- Medical Care Facilities — 54 companies, led by HCA Healthcare, Inc.
- Medical Instruments & Supplies — 50 companies, led by Intuitive Surgical, Inc.
- Diagnostics & Research — 45 companies, led by Thermo Fisher Scientific Inc.
- Health Information Services — 44 companies, led by Veeva Systems Inc.
- Drug Manufacturers - General — 21 companies, led by Eli Lilly and Company
- Healthcare Plans — 11 companies, led by UnitedHealth Group Incorporated
- Medical Distribution — 11 companies, led by McKesson Corporation
- Pharmaceutical Retailers — 6 companies, led by High Tide Inc.
Frequently Asked Questions
What is the largest Healthcare company?
The largest Healthcare company by market capitalization is Eli Lilly and Company (LLY), valued at $1.13T. Johnson & Johnson (JNJ) ranks as runner-up with a market cap of $621.22B. Market leadership can shift over time as earnings, valuations, and investor sentiment evolve.
How many Healthcare stocks pay dividends?
81 out of 1,092 Healthcare stocks (7%) pay dividends to shareholders. The average dividend yield stands at 1.91%. Investors seeking income should review each company's payout ratio and dividend history to assess sustainability.
What is the average P/E ratio in Healthcare?
The average P/E ratio across Healthcare sector stocks is currently 50.0x. This figure reflects collective earnings expectations and can vary significantly between sub-industries and individual companies. Comparing a stock's P/E to the sector average is a common way to identify potentially over- or under-valued opportunities.
Use StockVS to research Healthcare sector stocks in depth — explore individual company profiles, compare two companies side by side, and track key financial metrics across the sector. Whether you are screening for value, income, or growth, our data-driven tools help you make more informed investment decisions within the Healthcare sector.